Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
about
Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatmentPartial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasisTwenty-four hour efficacy of two dose levels of a once daily sustained-release diltiazem formulation in stable angina: a placebo-controlled trial. The Dildurang Study Group.Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse.Protective effects of diltiazem against vascular endothelial cell injury induced by angiotensin-II and hypoxia.Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers.Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension.Preparation and in vitro Evaluation of Ethylcellulose Coated Egg Albumin Microspheres of Diltiazem Hydrochloride.Effects of CP-060S, a novel cardioprotective drug, in the methacholine-induced ECG change model in rats.Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters.Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol.Playing with opening and closing of heterocycles: using the cusmano-ruccia reaction to develop a novel class of oxadiazolothiazinones, active as calcium channel modulators and P-glycoprotein inhibitors.Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.Validated gradient stability indicating HPLC method for determining Diltiazem Hydrochloride and related substances in bulk drug and novel tablet formulation.Effect of diltiazem on intraarterial blood pressure and heart rate during stress testing in patients with angina: a gender comparison study.Effect of cardiopulmonary bypass on plasma concentrations of diltiazem and its two active metabolites.Risk-based approach for systematic development of gastroretentive drug delivery system.Effects of lovastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by lovastatin.
P2860
Q24800752-DABF2B84-BCCD-4355-89BD-A37BF42583EFQ28472162-77C11A2E-AB3A-45A3-A537-DF8A4BB0433AQ34347031-9E726989-2A9C-4655-A299-20560024F3B6Q39011092-3947D9E7-7DBD-4349-A101-47F54F3FB3D4Q39042142-62CEC33A-1C83-409C-972C-29F552057774Q41676632-9B12DC6C-B085-4F49-ACA4-393E03C86A83Q41989844-C367B166-DC5D-42FA-BBAB-66809C24AFFAQ42288457-B2D44D71-1140-40D0-BD1B-2A548F1C73B6Q42592529-A960445D-5BC1-41B1-AC89-BAE5C18E1AD8Q43684601-85421204-7B07-44B0-A134-6C569ED42DF9Q44022101-AD2309BA-FAF5-4454-8027-238F6F1ABD17Q44970997-F5EA48AF-1B4D-47E4-8821-7A5035DD7283Q45136699-28FEBED1-636A-4262-B559-0171DFEB78BBQ45978234-35E19D4C-AF05-4A8A-A340-2C520BB02EE9Q49416486-357F9788-7749-4670-9EC9-7E44C8A95920Q50960417-965803DD-9DC2-4B69-8212-D81F9B3BE4D7Q51637276-9980F647-7A10-4B3B-AFB4-87E707FEA15DQ53051724-5DB62FD4-4208-433F-B5CF-EB3092CC39A6Q53848245-9BE197D6-F068-4C92-8CDB-32C62D78783C
P2860
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
@en
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
@nl
type
label
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
@en
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
@nl
prefLabel
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
@en
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
@nl
P2093
P1433
P1476
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.
@en
P2093
P304
P356
10.2165/00003495-199039050-00009
P577
1990-05-01T00:00:00Z
P6179
1014391947